Cargando…

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer

Liver metastasis from breast cancer is associated with poor prognosis and is a major cause of early morbidity and mortality. When liver resection is not feasible, minimally invasive directed therapies are considered to attempt to prolong survival. Selective internal radiation therapy (SIRT) with ytt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyon, Paul C., Winter, Helen, Herbschleb, Karin, Campo, Leticia, Carlisle, Robert, Wu, Feng, Goldin, Robert, Coussios, Constantin C., Middleton, Mark R., Gleeson, Fergus V., Boardman, Philip, Sharma, Ricky A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153140/
https://www.ncbi.nlm.nih.gov/pubmed/30258519
http://dx.doi.org/10.1016/j.radcr.2018.08.020
_version_ 1783357466801602560
author Lyon, Paul C.
Winter, Helen
Herbschleb, Karin
Campo, Leticia
Carlisle, Robert
Wu, Feng
Goldin, Robert
Coussios, Constantin C.
Middleton, Mark R.
Gleeson, Fergus V.
Boardman, Philip
Sharma, Ricky A.
author_facet Lyon, Paul C.
Winter, Helen
Herbschleb, Karin
Campo, Leticia
Carlisle, Robert
Wu, Feng
Goldin, Robert
Coussios, Constantin C.
Middleton, Mark R.
Gleeson, Fergus V.
Boardman, Philip
Sharma, Ricky A.
author_sort Lyon, Paul C.
collection PubMed
description Liver metastasis from breast cancer is associated with poor prognosis and is a major cause of early morbidity and mortality. When liver resection is not feasible, minimally invasive directed therapies are considered to attempt to prolong survival. Selective internal radiation therapy (SIRT) with yttrium-90 microspheres is a liver-directed therapy that can improve local control of liver metastases from colorectal cancer. We present a case of a patient with a ductal breast adenocarcinoma, who developed liver and bone metastasis despite extensive treatment with systemic chemotherapies. Following SIRT to the liver, after an initial response, the patient ultimately progressed in the liver after 7 months. Liver tumor histology obtained 20 months after the SIRT intervention demonstrated the presence of the resin microspheres in situ. This case report demonstrates the long-term control that may be achieved with SIRT to treat liver metastases from breast cancer that is refractory to previous chemotherapies, and the presence of microspheres in situ long-term.
format Online
Article
Text
id pubmed-6153140
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61531402018-09-26 Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer Lyon, Paul C. Winter, Helen Herbschleb, Karin Campo, Leticia Carlisle, Robert Wu, Feng Goldin, Robert Coussios, Constantin C. Middleton, Mark R. Gleeson, Fergus V. Boardman, Philip Sharma, Ricky A. Radiol Case Rep Interventional Radiology Liver metastasis from breast cancer is associated with poor prognosis and is a major cause of early morbidity and mortality. When liver resection is not feasible, minimally invasive directed therapies are considered to attempt to prolong survival. Selective internal radiation therapy (SIRT) with yttrium-90 microspheres is a liver-directed therapy that can improve local control of liver metastases from colorectal cancer. We present a case of a patient with a ductal breast adenocarcinoma, who developed liver and bone metastasis despite extensive treatment with systemic chemotherapies. Following SIRT to the liver, after an initial response, the patient ultimately progressed in the liver after 7 months. Liver tumor histology obtained 20 months after the SIRT intervention demonstrated the presence of the resin microspheres in situ. This case report demonstrates the long-term control that may be achieved with SIRT to treat liver metastases from breast cancer that is refractory to previous chemotherapies, and the presence of microspheres in situ long-term. Elsevier 2018-09-22 /pmc/articles/PMC6153140/ /pubmed/30258519 http://dx.doi.org/10.1016/j.radcr.2018.08.020 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Interventional Radiology
Lyon, Paul C.
Winter, Helen
Herbschleb, Karin
Campo, Leticia
Carlisle, Robert
Wu, Feng
Goldin, Robert
Coussios, Constantin C.
Middleton, Mark R.
Gleeson, Fergus V.
Boardman, Philip
Sharma, Ricky A.
Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
title Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
title_full Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
title_fullStr Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
title_full_unstemmed Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
title_short Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
title_sort long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
topic Interventional Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153140/
https://www.ncbi.nlm.nih.gov/pubmed/30258519
http://dx.doi.org/10.1016/j.radcr.2018.08.020
work_keys_str_mv AT lyonpaulc longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT winterhelen longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT herbschlebkarin longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT campoleticia longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT carlislerobert longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT wufeng longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT goldinrobert longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT coussiosconstantinc longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT middletonmarkr longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT gleesonfergusv longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT boardmanphilip longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer
AT sharmarickya longtermradiologicalandhistologicaloutcomesfollowingselectiveinternalradiationtherapytolivermetastasesfrombreastcancer